151 related articles for article (PubMed ID: 21683327)
1. Biomarkers in clinical practice.
Alpert JS
Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
[No Abstract] [Full Text] [Related]
2. BNP: not just for heart failure.
Nicholls MG; Frampton CM; Yandle TG
Heart; 2008 Jan; 94(1):6-7. PubMed ID: 18083945
[No Abstract] [Full Text] [Related]
3. [Redefinition of myocardial infarction--relevance of biomarkers].
Weber M; Hamm C
Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
[TBL] [Abstract][Full Text] [Related]
4. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
Javadzadeh J; Collén AC; Manhem K; Swedberg K
Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
[No Abstract] [Full Text] [Related]
5. Relationship of plasma erythropoietin to long-term outcome in acute coronary syndrome.
Szummer K; Lindahl B; Sylvén C; Jernberg T
Int J Cardiol; 2010 Aug; 143(2):165-70. PubMed ID: 19269703
[TBL] [Abstract][Full Text] [Related]
6. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
Palazzuoli A; Iovine F; Gallotta M; Nuti R
Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
[TBL] [Abstract][Full Text] [Related]
7. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction.
Lorgis L; Cottin Y; Danchin N; Mock L; Sicard P; Buffet P; L'huillier I; Richard C; Beer JC; Touzery C; Gambert P; Zeller M;
Heart; 2011 Apr; 97(7):551-6. PubMed ID: 21343169
[TBL] [Abstract][Full Text] [Related]
8. Long reach of the N-terminal of B-type natriuretic peptide.
SoRelle R
Circulation; 2002 Dec; 106(23):e9059. PubMed ID: 12460860
[No Abstract] [Full Text] [Related]
9. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
10. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
12. The influence of renal function on the prognostic value of NT-pro brain natriuretic peptide in ST-elevation myocardial infarction.
Lazzeri C; Valente S; Chiostri M; Attanà P; Picariello C; Gensini GF
Int J Cardiol; 2012 May; 156(3):333-5. PubMed ID: 22386698
[No Abstract] [Full Text] [Related]
13. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
14. [Do we need even more new biomarkers?].
Schnabel RB; Blankenberg S
Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
[No Abstract] [Full Text] [Related]
15. Natriuretic peptides in elderly people with acute myocardial infarction.
Ribeiro AL
BMJ; 2009 May; 338():b787. PubMed ID: 19420046
[No Abstract] [Full Text] [Related]
16. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
17. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
18. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP.
Squire I; Quinn P; Narayan H; Khan S; Dhillon O; Ng K; Kelly D; Davies J; Ng L
Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
